Skip to content

Duke Lupus Registry

Duke Lupus Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00512694
Enrollment
1000
Registered
2007-08-08
Start date
2007-07-31
Completion date
2028-06-30
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous Lupus, Systemic Lupus Erythematosus

Keywords

Lupus, Systemic Lupus Erythematosus, Cutaneous Lupus

Brief summary

Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women. The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.

Detailed description

The Duke Lupus Registry is a prospective cohort comprised of patients with lupus seen in the Duke Rheumatology clinic. The Duke Lupus Registry has two main purposes: 1. Improved patient care. By following disease activity scores and medication usage, we expect to improve our care of the patients seen in clinic. 2. Future research on lupus outcomes. This may encompass a broad array of areas, including but not limited to cardiovascular health, pregnancy and fertility, infections, medication use, quality of life, and depression. At each office visit, patients will complete a questionnaire, physicians will measure lupus activity, and patients may be asked to provide a small blood sample. Patients will not be required to make extra visits to Duke in order to participate -- all paperwork and blood draws will occur during a regularly scheduled office visit with the physician.

Interventions

None listed

Sponsors

Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus * Patient of a rheumatologist at Duke University Medical Center

Exclusion criteria

* Inability to travel to Duke for follow-up visits * Inability to speak English * Not able to provide informed consent

Countries

United States

Contacts

Primary ContactLaura Neil
laura.k.neil@duke.edu(919) 684-8936

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026